Regulation of obesity and insulin resistance by nitric oxide

Free Radical Biology and Medicine

Volumn 73, Issue , 2014, Pages 383-399

  Sansbury, Brian E ^a   Hill, Bradford G ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Diabetes; eNOS; Free radicals; Insulin resistance; Mitochondria; Nitric oxide; Obesity

Indexed keywords

GLUCOSE; INSULIN; LIPID; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTEIN KINASE B; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NOS3 PROTEIN, HUMAN;

CALORIC INTAKE; DIABETES MELLITUS; ENERGY EXPENDITURE; FOOD INTAKE; GLUCOSE METABOLISM; HUMAN; HUNGER; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTESTINE ABSORPTION; LIPID METABOLISM; METABOLIC DISORDER; NONHUMAN; OBESITY; PANCREAS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SATIETY; BODY COMPOSITION; DIET; ENERGY METABOLISM; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; PSYCHOPHYSIOLOGY;

ADIPOSITY; BODY COMPOSITION; DIET; ENERGY INTAKE; ENERGY METABOLISM; HUMANS; HUNGER; INSULIN RESISTANCE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; OBESITY; SATIETY RESPONSE;

EID: 84903541982     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2014.05.016     Document Type: Review

References (358)

1. R.S. Ahima Digging deeper into obesity J. Clin. Invest. 121 2011 2076 2079
2. C.L. Ogden, M.D. Carroll, B.K. Kit, and K.M. Flegal Prevalence of obesity in the United States, 2009-2010 NCHS Data Brief 82 2012 1 8
3. R.B. Ervin Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003-2006 Natl. Health Stat. Rep. 13 2009 1 7
4. V.L. Roger, A.S. Go, D.M. Lloyd-Jones, E.J. Benjamin, J.D. Berry, W.B. Borden, D.M. Bravata, S. Dai, E.S. Ford, C.S. Fox, H.J. Fullerton, C. Gillespie, S.M. Hailpern, J.A. Heit, V.J. Howard, B.M. Kissela, S.J. Kittner, D.T. Lackland, J.H. Lichtman, L.D. Lisabeth, D.M. Makuc, G.M. Marcus, A. Marelli, D.B. Matchar, C.S. Moy, D. Mozaffarian, M.E. Mussolino, G. Nichol, N.P. Paynter, E.Z. Soliman, P.D. Sorlie, N. Sotoodehnia, T.N. Turan, S.S. Virani, N.D. Wong, D. Woo, and M.B. Turner Heart disease and stroke statistics - 2012 update: a report from the American Heart Association Circulation 125 2012 e2 e220
5. E.E. Calle, M.J. Thun, J.M. Petrelli, C. Rodriguez, and C.W. Heath Jr. Body-mass index and mortality in a prospective cohort of U.S. adults N. Engl. J. Med. 341 1999 1097 1105 (Pubitemid 29466221)
6. L. Zamosky The obesity epidemic: while America swallows $147 billion in obesity-related healthcare costs, physicians called on to confront the crisis Med. Econ 90 2013 14 17
7. Y.H. Tseng, A.M. Cypess, and C.R. Kahn Cellular bioenergetics as a target for obesity therapy Nat. Rev. Drug Discovery 9 2010 465 482
8. A.K. Kant, and B.I. Graubard Eating out in America, 1987-2000: trends and nutritional correlates Prev. Med. 38 2004 243 249 (Pubitemid 38050296)
9. S.J. Nielsen, and B.M. Popkin Patterns and trends in food portion sizes, 1977-1998 JAMA 289 2003 450 453 (Pubitemid 36119965)
10. R.R. Briefel, and C.L. Johnson Secular trends in dietary intake in the United States Annu. Rev. Nutr. 24 2004 401 431 (Pubitemid 38938798)
11. J.O. Hill, and J.C. Peters Environmental contributions to the obesity epidemic Science 280 1998 1371 1374 (Pubitemid 28264817)
12. O.A. Jones, M.L. Maguire, and J.L. Griffin Environmental pollution and diabetes: a neglected association Lancet 371 2008 287 288 (Pubitemid 351754775)
13. A. Smink, N. Ribas-Fito, R. Garcia, M. Torrent, M.A. Mendez, J.O. Grimalt, and J. Sunyer Exposure to hexachlorobenzene during pregnancy increases the risk of overweight in children aged 6 years Acta Paediatr. 97 2008 1465 1469
14. Q. Sun, P. Yue, J.A. Deiuliis, C.N. Lumeng, T. Kampfrath, M.B. Mikolaj, Y. Cai, M.C. Ostrowski, B. Lu, S. Parthasarathy, R.D. Brook, S.D. Moffatt-Bruce, L.C. Chen, and S. Rajagopalan Ambient air pollution exaggerates adipose inflammation and insulin resistance in a mouse model of diet-induced obesity Circulation 119 2009 538 546
15. L.M. Schell, K.K. Burnitz, and P.W. Lathrop Pollution and human biology Ann. Hum. Biol. 37 2010 347 366
16. X. Xu, Z. Yavar, M. Verdin, Z. Ying, G. Mihai, T. Kampfrath, A. Wang, M. Zhong, M. Lippmann, L.C. Chen, S. Rajagopalan, and Q. Sun Effect of early particulate air pollution exposure on obesity in mice: role of p47phox Arterioscler. Thromb. Vasc. Biol. 30 2010 2518 2527
17. Y.H. Yan, C.C. Chou, C.T. Lee, J.Y. Liu, and T.J. Cheng Enhanced insulin resistance in diet-induced obese rats exposed to fine particles by instillation Inhalation Toxicol 23 2011 507 519
18. J.L. Bolton, S.H. Smith, N.C. Huff, M.I. Gilmour, W.M. Foster, R.L. Auten, and S.D. Bilbo Prenatal air pollution exposure induces neuroinflammation and predisposes offspring to weight gain in adulthood in a sex-specific manner FASEB J 26 2012 4743 4754
19. A. Rundle, L. Hoepner, A. Hassoun, S. Oberfield, G. Freyer, D. Holmes, M. Reyes, J. Quinn, D. Camann, F. Perera, and R. Whyatt Association of childhood obesity with maternal exposure to ambient air polycyclic aromatic hydrocarbons during pregnancy Am. J. Epidemiol. 175 2012 1163 1172
20. L.A. Cupul-Uicab, R. Skjaerven, K. Haug, K.K. Melve, S.M. Engel, and M.P. Longnecker In utero exposure to maternal tobacco smoke and subsequent obesity, hypertension, and gestational diabetes among women in the MoBa cohort Environ. Health Perspect. 120 2012 355 360
21. P. Langer, J. Ukropec, A. Kocan, B. Drobna, Z. Radikova, M. Huckova, R. Imrich, D. Gasperikova, I. Klimes, and T. Trnovec Obesogenic and diabetogenic impact of high organochlorine levels (HCB, p,p′-DDE, PCBs) on inhabitants in the highly polluted Eastern Slovakia Endocr. Regul. 48 2014 17 24
22. J.F. Sallis, M.F. Floyd, D.A. Rodriguez, and B.E. Saelens Role of built environments in physical activity, obesity, and cardiovascular disease Circulation 125 2012 729 737
23. D. Ding, J.F. Sallis, J. Kerr, S. Lee, and D.E. Rosenberg Neighborhood environment and physical activity among youth: a review Am. J. Prevent. Med 41 2011 442 455
24. C.P. Durand, M. Andalib, G.F. Dunton, J. Wolch, and M.A. Pentz A systematic review of built environment factors related to physical activity and obesity risk: implications for smart growth urban planning Obes. Rev. 12 2011 e173 182
25. L.C. Antunes, R. Levandovski, G. Dantas, W. Caumo, and M.P. Hidalgo Obesity and shift work: chronobiological aspects Nutr. Res. Rev. 23 2010 155 168
26. M. Garaulet, J.M. Ordovas, and J.A. Madrid The chronobiology, etiology and pathophysiology of obesity Int. J. Obes. 34 2010 1667 1683
27. E. Challet Circadian clocks, food intake, and metabolism Prog. Mol. Biol. Transl. Sci 119 2013 105 135
28. E. Widen, M. Lehto, T. Kanninen, J. Walston, A.R. Shuldiner, and L.C. Groop Association of a polymorphism in the beta 3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns N. Engl. J. Med. 333 1995 348 351
29. C. Bouchard, A. Tremblay, J.P. Despres, A. Nadeau, P.J. Lupien, G. Theriault, J. Dussault, S. Moorjani, S. Pinault, and G. Fournier The response to long-term overfeeding in identical twins N. Engl. J. Med. 322 1990 1477 1482 (Pubitemid 20179860)
30. C. Bouchard The biological predisposition to obesity: beyond the thrifty genotype scenario Int. J. Obes. (London) 31 2007 1337 1339 (Pubitemid 47339919)
31. J.C. Wells Thrift: a guide to thrifty genes, thrifty phenotypes and thrifty norms Int. J. Obes. 33 2009 1331 1338
32. L.M. Redman, L.K. Heilbronn, C.K. Martin, L. de Jonge, D.A. Williamson, J.P. Delany, and E Ravussin Metabolic and behavioral compensations in response to caloric restriction: implications for the maintenance of weight loss PLoS One 4 2009 e4377
33. R.L. Leibel, M. Rosenbaum, and J. Hirsch Changes in energy expenditure resulting from altered body weight N. Engl. J. Med. 332 1995 621 628
34. B.M. Spiegelman, and J.S. Flier Obesity and the regulation of energy balance Cell 104 2001 531 543 (Pubitemid 32201948)
35. R.S. Ahima, and J.S. Flier Leptin Annu. Rev. Physiol. 62 2000 413 437 (Pubitemid 30618269)
36. M.W. Schwartz, S.C. Woods, D. Porte Jr, R.J. Seeley, and D.G. Baskin Central nervous system control of food intake Nature 404 2000 661 671 (Pubitemid 30205071)
37. B.G. Stanley, S.E. Kyrkouli, S. Lampert, and S.F. Leibowitz Neuropeptide Y chronically injected into the hypothalamus: a powerful neurochemical inducer of hyperphagia and obesity Peptides 7 1986 1189 1192 (Pubitemid 17226746)
38. C.J. Billington, J.E. Briggs, S. Harker, M. Grace, and A.S. Levine Neuropeptide Y in hypothalamic paraventricular nucleus: a center coordinating energy metabolism Am. J. Physiol. 266 1994 R1765 1770
39. B. Beck, and G. Pourie Ghrelin, neuropeptide Y, and other feeding-regulatory peptides active in the hippocampus: role in learning and memory Nutr. Rev. 71 2013 541 561
40. G.A. Bray, and L.A. Tartaglia Medicinal strategies in the treatment of obesity Nature 404 2000 672 677 (Pubitemid 30205072)
41. M. Baretic Obesity drug therapy Minerva Endocrinol. 38 2013 245 254
42. C.F. Rueda-Clausen, R.S. Padwal, and A.M. Sharma New pharmacological approaches for obesity management Nat. Rev. Endocrinol 9 2013 467 478
43. K. Suzuki, K.A. Simpson, J.S. Minnion, J.C. Shillito, and S.R. Bloom The role of gut hormones and the hypothalamus in appetite regulation Endocr. J. 57 2010 359 372
44. N.M. Delzenne, P.D. Cani, and A.M. Neyrinck Modulation of glucagon-like peptide 1 and energy metabolism by inulin and oligofructose: experimental data J. Nutr. 137 2007 2547S 2551S (Pubitemid 350058733)
45. R. Guerciolini Mode of action of orlistat Int. J. Obes. Relat. Metab. Disord 21 Suppl. 3 1997 S12 23
46. M.E. Harper, K. Green, and M.D. Brand The efficiency of cellular energy transduction and its implications for obesity Annu. Rev. Nutr. 28 2008 13 33
47. W.C. Cutting, D.A. Rytand, and M.L. Tainter Relationship between blood cholesterol and increased metabolism from dinitrophenol and thyroid J. Clin. Invest. 13 1934 547 552
48. M.L. Tainter, W.C. Cutting, and A.B. Stockton Use of dinitrophenol in nutritional disorders: a critical survey of clinical results Am. J. Public Health Nations Health 24 1934 1045 1053
49. E. Colman Dinitrophenol and obesity: an early twentieth-century regulatory dilemma Regul. Toxicol. Pharmacol. 48 2007 115 117 (Pubitemid 46824157)
50. J. Kopecky, M. Rossmeisl, Z. Hodny, I. Syrovy, M. Horakova, and P. Kolarova Reduction of dietary obesity in aP2-Ucp transgenic mice: mechanism and adipose tissue morphology Am. J. Physiol. 270 1996 E776 786
51. B. Li, L.A. Nolte, J.S. Ju, D.H. Han, T. Coleman, J.O. Holloszy, and C.F. Semenkovich Skeletal muscle respiratory uncoupling prevents diet-induced obesity and insulin resistance in mice Nat. Med 6 2000 1115 1120
52. N.J. Rothwell, and M.J. Stock Luxuskonsumption, diet-induced thermogenesis and brown fat: the case in favour Clin. Sci. (London) 64 1983 19 23 (Pubitemid 13207247)
53. B.B. Lowell, and J.S. Flier Brown adipose tissue, beta 3-adrenergic receptors, and obesity Annu. Rev. Med 48 1997 307 316 (Pubitemid 27101833)
54. A.M. Cypess, S. Lehman, G. Williams, I. Tal, D. Rodman, A.B. Goldfine, F.C. Kuo, E.L. Palmer, Y.H. Tseng, A. Doria, G.M. Kolodny, and C.R. Kahn Identification and importance of brown adipose tissue in adult humans N. Engl. J. Med. 360 2009 1509 1517
55. K.A. Virtanen, M.E. Lidell, J. Orava, M. Heglind, R. Westergren, T. Niemi, M. Taittonen, J. Laine, N.J. Savisto, S. Enerback, and P. Nuutila Functional brown adipose tissue in healthy adults N. Engl. J. Med. 360 2009 1518 1525
56. L.P. Kozak, and M.E. Harper Mitochondrial uncoupling proteins in energy expenditure Annu. Rev. Nutr. 20 2000 339 363
57. A. Vidal-Puig, G. Solanes, D. Grujic, J.S. Flier, and B.B. Lowell UCP3: an uncoupling protein homologue expressed preferentially and abundantly in skeletal muscle and brown adipose tissue Biochem. Biophys. Res. Commun. 235 1997 79 82 (Pubitemid 27302688)
58. P. Puigserver, Z. Wu, C.W. Park, R. Graves, M. Wright, and B.M. Spiegelman A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis Cell 92 1998 829 839 (Pubitemid 28155321)
59. C. Handschin, and B.M. Spiegelman Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism Endocr. Rev. 27 2006 728 735 (Pubitemid 44936056)
60. D. Serra, P. Mera, M.I. Malandrino, J.F. Mir, and L. Herrero Mitochondrial fatty acid oxidation in obesity Antioxid. Redox Signaling 19 2013 269 284
61. P. Bostrom, J. Wu, M.P. Jedrychowski, A. Korde, L. Ye, J.C. Lo, K.A. Rasbach, E.A. Bostrom, J.H. Choi, J.Z. Long, S. Kajimura, M.C. Zingaretti, B.F. Vind, H. Tu, S. Cinti, K. Hojlund, S.P. Gygi, and B.M. Spiegelman A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis Nature 481 2012 463 468
62. B.G. Hill, B.P. Dranka, S.M. Bailey, J.R. Lancaster Jr, and V.M. Darley-Usmar What part of NO don't you understand? Some answers to the cardinal questions in nitric oxide biology J. Biol. Chem. 285 2010 19699 19704
63. J.S. Sir Sprigge Humphry Davy; his researches in respiratory physiology and his debt to Antoine Lavoisier Anaesthesia 57 2002 357 364
64. W.K. Alderton, C.E. Cooper, and R.G. Knowles Nitric oxide synthases: structure, function and inhibition Biochem. J. 357 2001 593 615 (Pubitemid 32735142)
65. H. Li, and T.L. Poulos Structure-function studies on nitric oxide synthases J. Inorg. Biochem. 99 2005 293 305 (Pubitemid 39642983)
66. D.M. Dudzinski, and T. Michel Life history of eNOS: partners and pathways Cardiovasc. Res. 75 2007 247 260 (Pubitemid 46961923)
67. W. Shen, J. Hao, Z. Feng, C. Tian, W. Chen, L. Packer, X. Shi, W. Zang, and J. Liu Lipoamide or lipoic acid stimulates mitochondrial biogenesis in 3T3-L1 adipocytes via the endothelial NO synthase-cGMP-protein kinase G signalling pathway Br. J. Pharmacol. 162 2011 1213 1224
68. L. Tedesco, A. Valerio, C. Cervino, A. Cardile, C. Pagano, R. Vettor, R. Pasquali, M.O. Carruba, G. Marsicano, B. Lutz, U. Pagotto, and E. Nisoli Cannabinoid type 1 receptor blockade promotes mitochondrial biogenesis through endothelial nitric oxide synthase expression in white adipocytes Diabetes 57 2008 2028 2036
69. Y. Mei, and S. Thevananther Endothelial nitric oxide synthase is a key mediator of hepatocyte proliferation in response to partial hepatectomy in mice Hepatology 54 2011 1777 1789
70. M. Vazquez-Chantada, U. Ariz, M. Varela-Rey, N. Embade, N. Martinez-Lopez, D. Fernandez-Ramos, L. Gomez-Santos, S. Lamas, S.C. Lu, M.L. Martinez-Chantar, and J.M. Mato Evidence for LKB1/AMP-activated protein kinase/endothelial nitric oxide synthase cascade regulated by hepatocyte growth factor, S-adenosylmethionine, and nitric oxide in hepatocyte proliferation Hepatology 49 2009 608 617
71. H. Zimmermann, P. Kurzen, W. Klossner, E.L. Renner, and U. Marti Decreased constitutive hepatic nitric oxide synthase expression in secondary biliary fibrosis and its changes after Roux-en-Y choledocho-jejunostomy in the rat J. Hepatol. 25 1996 567 573 (Pubitemid 26345903)
72. S. Oess, A. Icking, D. Fulton, R. Govers, and W. Muller-Esterl Subcellular targeting and trafficking of nitric oxide synthases Biochem. J. 396 2006 401 409 (Pubitemid 44228155)
73. W.C. Sessa eNOS at a glance J. Cell Sci. 117 2004 2427 2429 (Pubitemid 38877838)
74. J.L. Balligand, O. Feron, and C. Dessy eNOS activation by physical forces: from short-term regulation of contraction to chronic remodeling of cardiovascular tissues Physiol. Rev. 89 2009 481 534
75. B.C. Kone, T. Kuncewicz, W. Zhang, and Z.Y. Yu Protein interactions with nitric oxide synthases: controlling the right time, the right place, and the right amount of nitric oxide Am. J. Physiol. Renal Physiol 285 2003 F178 190
76. H. Kleinert, A. Pautz, K. Linker, and P.M. Schwarz Regulation of the expression of inducible nitric oxide synthase Eur. J. Pharmacol. 500 2004 255 266 (Pubitemid 39304013)
77. P.V. Finocchietto, M.C. Franco, S. Holod, A.S. Gonzalez, D.P. Converso, V.G. Arciuch, M.P. Serra, J.J. Poderoso, and M.C. Carreras Mitochondrial nitric oxide synthase: a masterpiece of metabolic adaptation, cell growth, transformation, and death Exp. Biol. Med. (Maywood) 234 2009 1020 1028
78. K. Kato, and C. Giulivi Critical overview of mitochondrial nitric-oxide synthase Front. Biosci. 11 2006 2725 2738 (Pubitemid 43806574)
79. D.A. Vitturi, and R.P. Patel Current perspectives and challenges in understanding the role of nitrite as an integral player in nitric oxide biology and therapy Free Radic. Biol. Med. 51 2011 805 812
80. J.O. Lundberg, M.T. Gladwin, A. Ahluwalia, N. Benjamin, N.S. Bryan, A. Butler, P. Cabrales, A. Fago, M. Feelisch, P.C. Ford, B.A. Freeman, M. Frenneaux, J. Friedman, M. Kelm, C.G. Kevil, D.B. Kim-Shapiro, A.V. Kozlov, J.R. Lancaster Jr, D.J. Lefer, K. McColl, K. McCurry, R.P. Patel, J. Petersson, T. Rassaf, V.P. Reutov, G.B. Richter-Addo, A. Schechter, S. Shiva, K. Tsuchiya, E.E. van Faassen, A.J. Webb, B.S. Zuckerbraun, J.L. Zweier, and E. Weitzberg Nitrate and nitrite in biology, nutrition and therapeutics Nat. Chem. Biol. 5 2009 865 869
81. 2 Proc. Natl. Acad. Sci. USA 98 2001 355 360
82. P. Pacher, J.S. Beckman, and L. Liaudet Nitric oxide and peroxynitrite in health and disease Physiol. Rev. 87 2007 315 424 (Pubitemid 46217686)
83. M. Trujillo, G. Ferrer-Sueta, and R. Radi Peroxynitrite detoxification and its biologic implications Antioxid. Redox Signaling 10 2008 1607 1620
84. C. Szabo, H. Ischiropoulos, and R. Radi Peroxynitrite: biochemistry, pathophysiology and development of therapeutics Nat. Rev. Drug Discovery 6 2007 662 680 (Pubitemid 47207751)
85. J.S. Beckman Understanding peroxynitrite biochemistry and its potential for treating human diseases Arch. Biochem. Biophys. 484 2009 114 116
86. J. McAndrew, R.P. Patel, H. Jo, T. Cornwell, T. Lincoln, D. Moellering, C.R. White, S. Matalon, and V. Darley-Usmar The interplay of nitric oxide and peroxynitrite with signal transduction pathways: implications for disease Semin. Perinatol. 21 1997 351 366 (Pubitemid 27459485)
87. B. Alvarez, and R. Radi Peroxynitrite reactivity with amino acids and proteins Amino Acids 25 2003 295 311 (Pubitemid 38041267)
88. S. Xu, J. Ying, B. Jiang, W. Guo, T. Adachi, V. Sharov, H. Lazar, J. Menzoian, T.V. Knyushko, D. Bigelow, C. Schoneich, and R.A. Cohen Detection of sequence-specific tyrosine nitration of manganese SOD and SERCA in cardiovascular disease and aging Am. J. Physiol. Heart Circ. Physiol 290 2006 H2220 2227
89. T. Koeck, D.J. Stuehr, and K.S. Aulak Mitochondria and regulated tyrosine nitration Biochem. Soc. Trans. 33 2005 1399 1403 (Pubitemid 41779698)
90. K.S. Aulak, M. Miyagi, L. Yan, K.A. West, D. Massillon, J.W. Crabb, and D.J. Stuehr Proteomic method identifies proteins nitrated in vivo during inflammatory challenge Proc. Natl. Acad. Sci. USA 98 2001 12056 12061 (Pubitemid 32959825)
91. B. Halliwell, and J.M. C. Gutteridge Free Radicals in Biology and Medicine 1998 Oxford Univ. Press Oxford
92. N. Hogg The biochemistry and physiology of S-nitrosothiols Annu. Rev. Pharmacol. Toxicol. 42 2002 585 600 (Pubitemid 34160536)
93. B.G. Hill, and A. Bhatnagar Role of glutathiolation in preservation, restoration and regulation of protein function IUBMB Life 59 2007 21 26
94. U. Forstermann, and W.C. Sessa Nitric oxide synthases: regulation and function Eur. Heart J. 33 2012 829 837 (837a-837d)
95. R.F. Furchgott, and J.V. Zawadzki The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine Nature 288 1980 373 376 (Pubitemid 11169009)
96. R.M. Rapoport, M.B. Draznin, and F. Murad Endothelium-dependent relaxation in rat aorta may be mediated through cyclic GMP-dependent protein phosphorylation Nature 306 1983 174 176 (Pubitemid 14228339)
97. R.M. Rapoport, and F. Murad Agonist-induced endothelium-dependent relaxation in rat thoracic aorta may be mediated through cGMP Circ. Res. 52 1983 352 357 (Pubitemid 13158751)
98. U. Forstermann, A. Mulsch, E. Bohme, and R. Busse Stimulation of soluble guanylate cyclase by an acetylcholine-induced endothelium-derived factor from rabbit and canine arteries Circ. Res. 58 1986 531 538 (Pubitemid 16102209)
99. J. Rajfer, W.J. Aronson, P.A. Bush, F.J. Dorey, and L.J. Ignarro Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission N. Engl. J. Med. 326 1992 90 94
100. S. Moncada, R.M. Palmer, and R.J. Gryglewski Mechanism of action of some inhibitors of endothelium-derived relaxing factor Proc. Natl. Acad. Sci. USA 83 1986 9164 9168 (Pubitemid 17223555)
101. R.J. Gryglewski, S. Moncada, and R.M. Palmer Bioassay of prostacyclin and endothelium-derived relaxing factor (EDRF) from porcine aortic endothelial cells Br. J. Pharmacol. 87 1986 685 694 (Pubitemid 16047532)
102. R.M. Palmer, A.G. Ferrige, and S. Moncada Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor Nature 327 1987 524 526 (Pubitemid 17085822)
103. N. Melikian, M.D. Seddon, B. Casadei, P.J. Chowienczyk, and A.M. Shah Neuronal nitric oxide synthase and human vascular regulation Trends Cardiovasc. Med 19 2009 256 262
104. H. Togashi, I. Sakuma, M. Yoshioka, T. Kobayashi, H. Yasuda, A. Kitabatake, H. Saito, S.S. Gross, and R. Levi A central nervous system action of nitric oxide in blood pressure regulation J. Pharmacol. Exp. Ther. 262 1992 343 347
105. I. Sakuma, H. Togashi, M. Yoshioka, H. Saito, M. Yanagida, M. Tamura, T. Kobayashi, H. Yasuda, S.S. Gross, and R. Levi NG-methyl-L-arginine, an inhibitor of L-arginine-derived nitric oxide synthesis, stimulates renal sympathetic nerve activity in vivo: a role for nitric oxide in the central regulation of sympathetic tone? Circ. Res. 70 1992 607 611
106. A.O. el Karib, J. Sheng, A.L. Betz, and R.L. Malvin The central effects of a nitric oxide synthase inhibitor (N omega-nitro-L-arginine) on blood pressure and plasma renin Clin. Exp. Hypertens. 15 1993 819 832 (Pubitemid 23248998)
107. N. Toda, K. Ayajiki, and T. Okamura Control of systemic and pulmonary blood pressure by nitric oxide formed through neuronal nitric oxide synthase J. Hypertens. 27 2009 1929 1940
108. N. Kim, K.M. Azadzoi, I. Goldstein, and I. Saenz de Tejada A nitric oxide-like factor mediates nonadrenergic-noncholinergic neurogenic relaxation of penile corpus cavernosum smooth muscle J. Clin. Invest. 88 1991 112 118
109. S. Shiva, J.Y. Oh, A.L. Landar, E. Ulasova, A. Venkatraman, S.M. Bailey, and V.M. Darley-Usmar Nitroxia: the pathological consequence of dysfunction in the nitric oxide-cytochrome c oxidase signaling pathway Free Radic. Biol. Med. 38 2005 297 306 (Pubitemid 40075573)
110. C.E. Cooper, and C. Giulivi Nitric oxide regulation of mitochondrial oxygen consumption. II. Molecular mechanism and tissue physiology Am. J. Physiol. Cell Physiol 292 2007 C1993 2003
111. M. Wolzt, R.J. MacAllister, D. Davis, M. Feelisch, S. Moncada, P. Vallance, and A.J. Hobbs Biochemical characterization of S-nitrosohemoglobin: mechanisms underlying synthesis, no release, and biological activity J. Biol. Chem. 274 1999 28983 28990
112. R.P. Patel, N. Hogg, N.Y. Spencer, B. Kalyanaraman, S. Matalon, and V.M. Darley-Usmar Biochemical characterization of human S-nitrosohemoglobin: effects on oxygen binding and transnitrosation J. Biol. Chem. 274 1999 15487 15492
113. D.P. Kelly, and R.C. Scarpulla Transcriptional regulatory circuits controlling mitochondrial biogenesis and function Genes Dev. 18 2004 357 368 (Pubitemid 38316342)
114. E. Nisoli, E. Clementi, C. Paolucci, V. Cozzi, C. Tonello, C. Sciorati, R. Bracale, A. Valerio, M. Francolini, S. Moncada, and M.O. Carruba Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide Science 299 2003 896 899 (Pubitemid 36182449)
115. E. Nisoli, S. Falcone, C. Tonello, V. Cozzi, L. Palomba, M. Fiorani, A. Pisconti, S. Brunelli, A. Cardile, M. Francolini, O. Cantoni, M.O. Carruba, S. Moncada, and E. Clementi Mitochondrial biogenesis by NO yields functionally active mitochondria in mammals Proc. Natl. Acad. Sci. USA 101 2004 16507 16512 (Pubitemid 39557743)
116. S.B. Bender, E.K. Herrick, N.D. Lott, and R.E. Klabunde Diet-induced obesity and diabetes reduce coronary responses to nitric oxide due to reduced bioavailability in isolated mouse hearts Diabetes Obes. Metab. 9 2007 688 696 (Pubitemid 47261850)
117. F. Kim, M. Pham, E. Maloney, N.O. Rizzo, G.J. Morton, B.E. Wisse, E.A. Kirk, A. Chait, and M.W. Schwartz Vascular inflammation, insulin resistance, and reduced nitric oxide production precede the onset of peripheral insulin resistance Arterioscler. Thromb. Vasc. Biol. 28 2008 1982 1988
118. Y. Higashi, S. Sasaki, K. Nakagawa, H. Matsuura, K. Chayama, and T. Oshima Effect of obesity on endothelium-dependent, nitric oxide-mediated vasodilation in normotensive individuals and patients with essential hypertension Am. J. Hypertens. 14 2001 1038 1045 (Pubitemid 32978077)
119. H.J. Gruber, C. Mayer, H. Mangge, G. Fauler, N. Grandits, and M. Wilders-Truschnig Obesity reduces the bioavailability of nitric oxide in juveniles Int. J. Obes. 32 2008 826 831 (Pubitemid 351670620)
120. A. Georgescu, D. Popov, A. Constantin, M. Nemecz, N. Alexandru, D. Cochior, and A. Tudor Dysfunction of human subcutaneous fat arterioles in obesity alone or obesity associated with type 2 diabetes Clin. Sci. 120 2011 463 472
121. P. Perez-Matute, M.J. Neville, G.D. Tan, K.N. Frayn, and F. Karpe Transcriptional control of human adipose tissue blood flow Obesity 17 2009 681 688
122. B.E. Sansbury, T.D. Cummins, Y. Tang, J. Hellmann, C.R. Holden, M.A. Harbeson, Y. Chen, R.P. Patel, M. Spite, A. Bhatnagar, and B.G. Hill Overexpression of endothelial nitric oxide synthase prevents diet-induced obesity and regulates adipocyte phenotype Circ. Res. 111 2012 1176 1189
123. A. Valerio, A. Cardile, V. Cozzi, R. Bracale, L. Tedesco, A. Pisconti, L. Palomba, O. Cantoni, E. Clementi, S. Moncada, M.O. Carruba, and E. Nisoli TNF-alpha downregulates eNOS expression and mitochondrial biogenesis in fat and muscle of obese rodents J. Clin. Invest. 116 2006 2791 2798 (Pubitemid 44511642)
124. R.M. Kraus, J.A. Houmard, W.E. Kraus, C.J. Tanner, J.R. Pierce, M.D. Choi, and R.C. Hickner Obesity, insulin resistance, and skeletal muscle nitric oxide synthase J. Appl. Physiol. (1985) 113 2012 758 765
125. M.A. Awolesi, W.C. Sessa, and B.E. Sumpio Cyclic strain upregulates nitric oxide synthase in cultured bovine aortic endothelial cells J. Clin. Invest. 96 1995 1449 1454
126. A. Zembowicz, J.L. Tang, and K.K. Wu Transcriptional induction of endothelial nitric oxide synthase type III by lysophosphatidylcholine J. Biol. Chem. 270 1995 17006 17010
127. K. Hirata, N. Miki, Y. Kuroda, T. Sakoda, S. Kawashima, and M. Yokoyama Low concentration of oxidized low-density lipoprotein and lysophosphatidylcholine upregulate constitutive nitric oxide synthase mRNA expression in bovine aortic endothelial cells Circ. Res. 76 1995 958 962
128. G. Zeng, F.H. Nystrom, L.V. Ravichandran, L.N. Cong, M. Kirby, H. Mostowski, and M.J. Quon Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells Circulation 101 2000 1539 1545 (Pubitemid 30180890)
129. R. Hambrecht, A. Wolf, S. Gielen, A. Linke, J. Hofer, S. Erbs, N. Schoene, and G. Schuler Effect of exercise on coronary endothelial function in patients with coronary artery disease N. Engl. J. Med. 342 2000 454 460 (Pubitemid 30100232)
130. G.S. Hotamisligil, N.S. Shargill, and B.M. Spiegelman Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance Science 259 1993 87 91 (Pubitemid 23036092)
131. T. Michel, and S. Lamas Molecular cloning of constitutive endothelial nitric oxide synthase: evidence for a family of related genes J. Cardiovasc. Pharmacol. 20 Suppl. 12 1992 S45 49
132. P.F. Lai, F. Mohamed, J.C. Monge, and D.J. Stewart Downregulation of eNOS mRNA expression by TNFalpha: identification and functional characterization of RNA-protein interactions in the 3′UTR Cardiovasc. Res. 59 2003 160 168 (Pubitemid 36776382)
133. P. Neumann, N. Gertzberg, and A. Johnson TNF-alpha induces a decrease in eNOS promoter activity Am. J. Physiol. Lung Cell Mol. Physiol 286 2004 L452 459
134. H.D. Anderson, D. Rahmutula, and D.G. Gardner Tumor necrosis factor-alpha inhibits endothelial nitric-oxide synthase gene promoter activity in bovine aortic endothelial cells J. Biol. Chem. 279 2004 963 969 (Pubitemid 38082617)
135. J. Alonso, L. Sanchez de Miguel, M. Monton, S. Casado, and A. Lopez-Farre Endothelial cytosolic proteins bind to the 3′ untranslated region of endothelial nitric oxide synthase mRNA: regulation by tumor necrosis factor alpha Mol. Cell. Biol. 17 1997 5719 5726 (Pubitemid 27411079)
136. L. Sanchez de Miguel, J. Alonso, F. Gonzalez-Fernandez, J. de la Osada, M. Monton, J.A. Rodriguez-Feo, J.I. Guerra, M.M. Arriero, L. Rico, S. Casado, and A. Lopez-Farre Evidence that an endothelial cytosolic protein binds to the 3′-untranslated region of endothelial nitric oxide synthase mRNA J. Vasc. Res. 36 1999 201 208 (Pubitemid 29291196)
137. M. Yoshizumi, M.A. Perrella, J.C. Burnett Jr, and M.E. Lee Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life Circ. Res. 73 1993 205 209 (Pubitemid 23173071)
138. G. Yan, B. You, S.P. Chen, J.K. Liao, and J. Sun Tumor necrosis factor-alpha downregulates endothelial nitric oxide synthase mRNA stability via translation elongation factor 1-alpha 1 Circ. Res. 103 2008 591 597
139. S. Bulotta, R. Barsacchi, D. Rotiroti, N. Borgese, and E. Clementi Activation of the endothelial nitric-oxide synthase by tumor necrosis factor-alpha: a novel feedback mechanism regulating cell death J. Biol. Chem. 276 2001 6529 6536
140. H. Kawanaka, M.K. Jones, I.L. Szabo, D. Baatar, R. Pai, K. Tsugawa, K. Sugimachi, I.J. Sarfeh, and A.S. Tarnawski Activation of eNOS in rat portal hypertensive gastric mucosa is mediated by TNF-alpha via the PI 3-kinase-Akt signaling pathway Hepatology 35 2002 393 402 (Pubitemid 34106380)
141. R. Barsacchi, C. Perrotta, S. Bulotta, S. Moncada, N. Borgese, and E. Clementi Activation of endothelial nitric-oxide synthase by tumor necrosis factor-alpha: a novel pathway involving sequential activation of neutral sphingomyelinase, phosphatidylinositol-3′ kinase, and Akt Mol. Pharmacol. 63 2003 886 895 (Pubitemid 36368996)
142. C. De Palma, E. Meacci, C. Perrotta, P. Bruni, and E. Clementi Endothelial nitric oxide synthase activation by tumor necrosis factor alpha through neutral sphingomyelinase 2, sphingosine kinase 1, and sphingosine 1 phosphate receptors: a novel pathway relevant to the pathophysiology of endothelium Arterioscler. Thromb. Vasc. Biol. 26 2006 99 105 (Pubitemid 43732234)
143. N.D. Vaziri, and X.Q. Wang cGMP-mediated negative-feedback regulation of endothelial nitric oxide synthase expression by nitric oxide Hypertension 34 1999 1237 1241
144. I.M. Grumbach, W. Chen, S.A. Mertens, and D.G. Harrison A negative feedback mechanism involving nitric oxide and nuclear factor kappa-B modulates endothelial nitric oxide synthase transcription J. Mol. Cell. Cardiol. 39 2005 595 603 (Pubitemid 41331048)
145. M.X. Zhang, H. Ou, Y.H. Shen, J. Wang, J. Wang, J. Coselli, and X.L. Wang Regulation of endothelial nitric oxide synthase by small RNA Proc. Natl. Acad. Sci. USA 102 2005 16967 16972 (Pubitemid 41692667)
146. M. Shimabukuro, M. Ohneda, Y. Lee, and R.H. Unger Role of nitric oxide in obesity-induced beta cell disease J. Clin. Invest. 100 1997 290 295 (Pubitemid 27349075)
147. B.T. Noronha, J.M. Li, S.B. Wheatcroft, A.M. Shah, and M.T. Kearney Inducible nitric oxide synthase has divergent effects on vascular and metabolic function in obesity Diabetes 54 2005 1082 1089 (Pubitemid 40446322)
148. H. Sugita, M. Fujimoto, T. Yasukawa, N. Shimizu, M. Sugita, S. Yasuhara, J.A. Martyn, and M. Kaneki Inducible nitric-oxide synthase and NO donor induce insulin receptor substrate-1 degradation in skeletal muscle cells J. Biol. Chem. 280 2005 14203 14211 (Pubitemid 40517322)
149. S.K. Mantena, D.P. Vaughn, K.K. Andringa, H.B. Eccleston, A.L. King, G.A. Abrams, J.E. Doeller, D.W. Kraus, V.M. Darley-Usmar, and S.M. Bailey High fat diet induces dysregulation of hepatic oxygen gradients and mitochondrial function in vivo Biochem. J. 417 2009 183 193
150. M. Fujimoto, N. Shimizu, K. Kunii, J.A. Martyn, K. Ueki, and M. Kaneki A role for iNOS in fasting hyperglycemia and impaired insulin signaling in the liver of obese diabetic mice Diabetes 54 2005 1340 1348 (Pubitemid 40586662)
151. S.P. Weisberg, D. McCann, M. Desai, M. Rosenbaum, R.L. Leibel, and A.W.
152. C.N. Lumeng, J.L. Bodzin, and A.R. Saltiel Obesity induces a phenotypic switch in adipose tissue macrophage polarization J. Clin. Invest. 117 2007 175 184 (Pubitemid 46048464)
153. C.N. Lumeng, S.M. Deyoung, J.L. Bodzin, and A.R. Saltiel Increased inflammatory properties of adipose tissue macrophages recruited during diet-induced obesity Diabetes 56 2007 16 23
154. C. Merial, A. Bouloumie, V. Trocheris, M. Lafontan, and J. Galitzky Nitric oxide-dependent downregulation of adipocyte UCP-2 expression by tumor necrosis factor-alpha Am. J. Physiol. Cell Physiol 279 2000 C1100 1106
155. C.J. Sadler, and J.P. Wilding Reduced ventromedial hypothalamic neuronal nitric oxide synthase and increased sensitivity to NOS inhibition in dietary obese rats: further evidence of a role for nitric oxide in the regulation of energy balance Brain Res. 1016 2004 222 228 (Pubitemid 38887705)
156. S. Benkhoff, A.E. Loot, I. Pierson, A. Sturza, K. Kohlstedt, I. Fleming, H. Shimokawa, O. Grisk, R.P. Brandes, and K. Schroder Leptin potentiates endothelium-dependent relaxation by inducing endothelial expression of neuronal NO synthase Arterioscler. Thromb. Vasc. Biol. 32 2012 1605 1612
157. P.L. eNOS Huang metabolic syndrome and cardiovascular disease Trends Endocrinol. Metab. 20 2009 295 302
158. R. Rafikov, F.V. Fonseca, S. Kumar, D. Pardo, C. Darragh, S. Elms, D. Fulton, and S.M. Black eNOS activation and NO function: structural motifs responsible for the posttranslational control of endothelial nitric oxide synthase activity J. Endocrinol. 210 2011 271 284
159. H. Ju, R. Zou, V.J. Venema, and R.C. Venema Direct interaction of endothelial nitric-oxide synthase and caveolin-1 inhibits synthase activity J. Biol. Chem. 272 1997 18522 18525 (Pubitemid 27318186)
160. 2+-calmodulin and caveolin J. Biol. Chem. 272 1997 15583 15586 (Pubitemid 27265522)
161. N. Yang, C. Ying, M. Xu, X. Zuo, X. Ye, L. Liu, Y. Nara, and X. Sun High-fat diet up-regulates caveolin-1 expression in aorta of diet-induced obese but not in diet-resistant rats Cardiovasc. Res. 76 2007 167 174 (Pubitemid 47362043)
162. B.T. Bikman, and S.A. Summers Ceramides as modulators of cellular and whole-body metabolism J. Clin. Invest. 121 2011 4222 4230
163. Q.J. Zhang, W.L. Holland, L. Wilson, J.M. Tanner, D. Kearns, J.M. Cahoon, D. Pettey, J. Losee, B. Duncan, D. Gale, C.A. Kowalski, N. Deeter, A. Nichols, M. Deesing, C. Arrant, T. Ruan, C. Boehme, D.R. McCamey, J. Rou, K. Ambal, K. K Narra, S.A. Summers, E.D. Abel, and J.D. Symons Ceramide mediates vascular dysfunction in diet-induced obesity by PP2A-mediated dephosphorylation of the eNOS-Akt complex Diabetes 61 2012 1848 1859
164. J.P. Gratton, J. Fontana, D.S. O'Connor, G. Garcia-Cardena, T.J. McCabe, and W.C. Sessa Reconstitution of an endothelial nitric-oxide synthase (eNOS), hsp90, and caveolin-1 complex in vitro: evidence that hsp90 facilitates calmodulin stimulated displacement of eNOS from caveolin-1 J. Biol. Chem. 275 2000 22268 22272 (Pubitemid 30621809)
165. T.J. McCabe, D. Fulton, L.J. Roman, and W.C. Sessa Enhanced electron flux and reduced calmodulin dissociation may explain "calcium-independent" eNOS activation by phosphorylation J. Biol. Chem. 275 2000 6123 6128 (Pubitemid 30129896)
166. J.W. Elrod, M.R. Duranski, W. Langston, J.J. Greer, L. Tao, T.R. Dugas, C.G. Kevil, H.C. Champion, and D.J. Lefer eNOS gene therapy exacerbates hepatic ischemia-reperfusion injury in diabetes: a role for eNOS uncoupling Circ. Res. 99 2006 78 85 (Pubitemid 44297058)
167. J.C. Zhong, X.Y. Yu, Y. Huang, L.M. Yung, C.W. Lau, and S.G. Lin Apelin modulates aortic vascular tone via endothelial nitric oxide synthase phosphorylation pathway in diabetic mice Cardiovasc. Res. 74 2007 388 395 (Pubitemid 46693698)
168. Q. Li, D. Atochin, S. Kashiwagi, J. Earle, A. Wang, E. Mandeville, K. Hayakawa, L.V. d'Uscio, E.H. Lo, Z. Katusic, W. Sessa, and P.L. Huang Deficient eNOS phosphorylation is a mechanism for diabetic vascular dysfunction contributing to increased stroke size Stroke 44 2013 3183 3188
169. K. Taguchi, T. Kobayashi, T. Matsumoto, and K. Kamata Dysfunction of endothelium-dependent relaxation to insulin via PKC-mediated GRK2/Akt activation in aortas of ob/ob mice Am. J. Physiol. Heart Circ. Physiol 301 2011 H571 583
170. F. Kim, M. Pham, I. Luttrell, D.D. Bannerman, J. Tupper, J. Thaler, T.R. Hawn, E.W. Raines, and M.W. Schwartz Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity Circ. Res. 100 2007 1589 1596 (Pubitemid 46897262)
171. J.D. Symons, S.L. McMillin, C. Riehle, J. Tanner, M. Palionyte, E. Hillas, D. Jones, R.C. Cooksey, M.J. Birnbaum, D.A. McClain, Q.J. Zhang, D. Gale, L.J. Wilson, and E.D. Abel Contribution of insulin and Akt1 signaling to endothelial nitric oxide synthase in the regulation of endothelial function and blood pressure Circ. Res. 104 2009 1085 1094
172. K. Naruse, C. Rask-Madsen, N. Takahara, S.W. Ha, K. Suzuma, K.J. Way, J.R. Jacobs, A.C. Clermont, K. Ueki, Y. Ohshiro, J. Zhang, A.B. Goldfine, and G.L. King Activation of vascular protein kinase C-beta inhibits Akt-dependent endothelial nitric oxide synthase function in obesity-associated insulin resistance Diabetes 55 2006 691 698 (Pubitemid 43343225)
173. H.G. Zecchin, F.B. Priviero, C.T. Souza, K.G. Zecchin, P.O. Prada, J.B. Carvalheira, L.A. Velloso, E. Antunes, and M.J. Saad Defective insulin and acetylcholine induction of endothelial cell-nitric oxide synthase through insulin receptor substrate/Akt signaling pathway in aorta of obese rats Diabetes 56 2007 1014 1024 (Pubitemid 46525080)
174. K. Park, Q. Li, C. Rask-Madsen, A. Mima, K. Mizutani, J. Winnay, Y. Maeda, K. D'Aquino, M.F. White, E.P. Feener, and G.L. King Serine phosphorylation sites on IRS2 activated by angiotensin II and protein kinase C to induce selective insulin resistance in endothelial cells Mol. Cell. Biol. 33 2013 3227 3241
175. C.C. Low Wang, L. Lu, J.W. Leitner, M. Sarraf, R. Gianani, B. Draznin, C.R. Greyson, J.E. Reusch, and G.G. Schwartz Arterial insulin resistance in Yucatan micropigs with diet-induced obesity and metabolic syndrome J. Diabetes Complications 27 2013 307 315
176. S. Dimmeler, I. Fleming, B. Fisslthaler, C. Hermann, R. Busse, and A.M. Zeiher Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation Nature 399 1999 601 605
177. C. Hermann, B. Assmus, C. Urbich, A.M. Zeiher, and S. Dimmeler Insulin-mediated stimulation of protein kinase Akt: a potent survival signaling cascade for endothelial cells Arterioscler. Thromb. Vasc. Biol. 20 2000 402 409 (Pubitemid 30086096)
178. E.R. Duncan, P.A. Crossey, S. Walker, N. Anilkumar, L. Poston, G. Douglas, V.A. Ezzat, S.B. Wheatcroft, A.M. Shah, and M.T. Kearney Effect of endothelium-specific insulin resistance on endothelial function in vivo Diabetes 57 2008 3307 3314
179. T. Kubota, N. Kubota, H. Kumagai, S. Yamaguchi, H. Kozono, T. Takahashi, M. Inoue, S. Itoh, I. Takamoto, T. Sasako, K. Kumagai, T. Kawai, S. Hashimoto, T. Kobayashi, M. Sato, K. Tokuyama, S. Nishimura, M. Tsunoda, T. Ide, K. Murakami, T. Yamazaki, O. Ezaki, K. Kawamura, H. Masuda, M. Moroi, K. Sugi, Y. Oike, H. Shimokawa, N. Yanagihara, M. Tsutsui, Y. Terauchi, K. Tobe, R. Nagai, K. Kamata, K. Inoue, T. Kodama, K. Ueki, and T. Kadowaki Impaired insulin signaling in endothelial cells reduces insulin-induced glucose uptake by skeletal muscle Cell Metab. 13 2011 294 307
180. F. Kim, K.A. Tysseling, J. Rice, M. Pham, L. Haji, B.M. Gallis, A.S. Baas, P. Paramsothy, C.M. Giachelli, M.A. Corson, and E.W. Raines Free fatty acid impairment of nitric oxide production in endothelial cells is mediated by IKKbeta Arterioscler. Thromb. Vasc. Biol. 25 2005 989 994 (Pubitemid 40627844)
181. I. Edirisinghe, K. McCormick Hallam, and C.T. Kappagoda Effect of fatty acids on endothelium-dependent relaxation in the rabbit aorta Clin. Sci. 111 2006 145 151 (Pubitemid 44220528)
182. X. Du, D. Edelstein, S. Obici, N. Higham, M.H. Zou, and M. Brownlee Insulin resistance reduces arterial prostacyclin synthase and eNOS activities by increasing endothelial fatty acid oxidation J. Clin. Invest. 116 2006 1071 1080
183. H.O. Steinberg, G. Paradisi, G. Hook, K. Crowder, J. Cronin, and A.D. Baron Free fatty acid elevation impairs insulin-mediated vasodilation and nitric oxide production Diabetes 49 2000 1231 1238 (Pubitemid 30439100)
184. H.O. Steinberg, M. Tarshoby, R. Monestel, G. Hook, J. Cronin, A. Johnson, B. Bayazeed, and A.D. Baron Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation J. Clin. Invest. 100 1997 1230 1239 (Pubitemid 27386309)
185. Q. Yu, F. Gao, and X.L. Ma Insulin says NO to cardiovascular disease Cardiovasc. Res. 89 2011 516 524
186. H.J. Jang, H.S. Kim, D.H. Hwang, M.J. Quon, and J.A. Kim Toll-like receptor 2 mediates high-fat diet-induced impairment of vasodilator actions of insulin Am. J. Physiol. Endocrinol. Metab. 304 2013 E1077 1088
187. X.L. Du, D. Edelstein, S. Dimmeler, Q. Ju, C. Sui, and M. Brownlee Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site J. Clin. Invest. 108 2001 1341 1348 (Pubitemid 33107762)
188. D.S. Calnek, L. Mazzella, S. Roser, J. Roman, and C.M. Hart Peroxisome proliferator-activated receptor gamma ligands increase release of nitric oxide from endothelial cells Arterioscler. Thromb. Vasc. Biol. 23 2003 52 57 (Pubitemid 36091625)
189. D.H. Cho, Y.J. Choi, S.A. Jo, and I. Jo Nitric oxide production and regulation of endothelial nitric-oxide synthase phosphorylation by prolonged treatment with troglitazone: evidence for involvement of peroxisome proliferator-activated receptor (PPAR) gamma-dependent and PPARgamma-independent signaling pathways J. Biol. Chem. 279 2004 2499 2506 (Pubitemid 38114233)
190. J.A. Polikandriotis, L.J. Mazzella, H.L. Rupnow, and C.M. Hart Peroxisome proliferator-activated receptor gamma ligands stimulate endothelial nitric oxide production through distinct peroxisome proliferator-activated receptor gamma-dependent mechanisms Arterioscler. Thromb. Vasc. Biol. 25 2005 1810 1816 (Pubitemid 41243447)
191. K. Goya, S. Sumitani, M. Otsuki, X. Xu, H. Yamamoto, S. Kurebayashi, H. Saito, H. Kouhara, and S. Kasayama The thiazolidinedione drug troglitazone up-regulates nitric oxide synthase expression in vascular endothelial cells J. Diabetes Complications 20 2006 336 342 (Pubitemid 44292533)
192. B.J. Davis, Z. Xie, B. Viollet, and M.H. Zou Activation of the AMP-activated kinase by antidiabetes drug metformin stimulates nitric oxide synthesis in vivo by promoting the association of heat shock protein 90 and endothelial nitric oxide synthase Diabetes 55 2006 496 505 (Pubitemid 43343281)
193. M. Li, G. Pascual, and C.K. Glass Peroxisome proliferator-activated receptor gamma-dependent repression of the inducible nitric oxide synthase gene Mol. Cell. Biol. 20 2000 4699 4707 (Pubitemid 30396117)
194. L.B. Maggi Jr, H. Sadeghi, C. Weigand, A.L. Scarim, M.R. Heitmeier, and J.A. Corbett Anti-inflammatory actions of 15-deoxy-delta 12,14-prostaglandin J2 and troglitazone: evidence for heat shock-dependent and -independent inhibition of cytokine-induced inducible nitric oxide synthase expression Diabetes 49 2000 346 355 (Pubitemid 30131779)
195. M.T. Heneka, T. Klockgether, and D.L. Feinstein Peroxisome proliferator-activated receptor-gamma ligands reduce neuronal inducible nitric oxide synthase expression and cell death in vivo J. Neurosci. 20 2000 6862 6867
196. P.C. Konturek, T. Brzozowski, J. Kania, S.J. Konturek, S. Kwiecien, R. Pajdo, and E.G. Hahn Pioglitazone, a specific ligand of peroxisome proliferator-activated receptor-gamma, accelerates gastric ulcer healing in rat Eur. J. Pharmacol. 472 2003 213 220 (Pubitemid 37271918)
197. M. Mendez, and M.C. LaPointe PPARgamma inhibition of cyclooxygenase-2, PGE2 synthase, and inducible nitric oxide synthase in cardiac myocytes Hypertension 42 2003 844 850 (Pubitemid 37237334)
198. M.B. Crosby, J.L. Svenson, J. Zhang, C.J. Nicol, F.J. Gonzalez, and G.S. Gilkeson Peroxisome proliferation-activated receptor (PPAR)gamma is not necessary for synthetic PPARgamma agonist inhibition of inducible nitric-oxide synthase and nitric oxide J. Pharmacol. Exp. Ther. 312 2005 69 76 (Pubitemid 40096454)
199. I. Rodriguez-Crespo, N.C. Gerber, and P.R. Ortiz de Montellano Endothelial nitric-oxide synthase: expression in Escherichia coli, spectroscopic characterization, and role of tetrahydrobiopterin in dimer formation J. Biol. Chem. 271 1996 11462 11467
200. I. Rodriguez-Crespo, and P.R. Ortiz de Montellano Human endothelial nitric oxide synthase: expression in Escherichia coli, coexpression with calmodulin, and characterization Arch. Biochem. Biophys. 336 1996 151 156 (Pubitemid 26423761)
201. N.J. Alp, and K.M. Channon Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease Arterioscler. Thromb. Vasc. Biol. 24 2004 413 420 (Pubitemid 38326132)
202. H. Li, and U. Forstermann Uncoupling of endothelial NO synthase in atherosclerosis and vascular disease Curr. Opin. Pharmacol. 13 2013 161 167
203. J.L. Zweier, C.A. Chen, and L.J. Druhan S-glutathionylation reshapes our understanding of endothelial nitric oxide synthase uncoupling and nitric oxide/reactive oxygen species-mediated signaling Antioxid. Redox Signaling 14 2011 1769 1775
204. K.M. Channon Tetrahydrobiopterin: a vascular redox target to improve endothelial function Curr. Vasc. Pharmacol 10 2012 705 708
205. H. Ding, and C.R. Triggle Endothelial dysfunction in diabetes: multiple targets for treatment Pflugers Arch. 459 2010 977 994
206. P.N. Chander, O. Gealekman, S.V. Brodsky, S. Elitok, A. Tojo, M. Crabtree, S.S. Gross, and M.S. Goligorsky Nephropathy in Zucker diabetic fat rat is associated with oxidative and nitrosative stress: prevention by chronic therapy with a peroxynitrite scavenger ebselen J. Am. Soc. Nephrol. 15 2004 2391 2403 (Pubitemid 39159339)
207. - imbalance in insulin-resistant rat aorta Diabetes 48 1999 2437 2445 (Pubitemid 30395437)
208. M. Pannirselvam, S. Verma, T.J. Anderson, and C.R. Triggle Cellular basis of endothelial dysfunction in small mesenteric arteries from spontaneously diabetic (db/db -/-) mice: role of decreased tetrahydrobiopterin bioavailability Br. J. Pharmacol. 136 2002 255 263 (Pubitemid 34587672)
209. S. Cai, J. Khoo, and K.M. Channon Augmented BH4 by gene transfer restores nitric oxide synthase function in hyperglycemic human endothelial cells Cardiovasc. Res. 65 2005 823 831 (Pubitemid 40249727)
210. M.J. Crabtree, C.L. Smith, G. Lam, M.S. Goligorsky, and S.S. Gross Ratio of 5,6,7,8-tetrahydrobiopterin to 7,8-dihydrobiopterin in endothelial cells determines glucose-elicited changes in NO vs. superoxide production by eNOS Am. J. Physiol. Heart Circ. Physiol 294 2008 H1530 1540
211. U. Forstermann, and H. Li Therapeutic effect of enhancing endothelial nitric oxide synthase (eNOS) expression and preventing eNOS uncoupling Br. J. Pharmacol. 164 2011 213 223
212. R. Kietadisorn, R.P. Juni, and A.L. Moens Tackling endothelial dysfunction by modulating NOS uncoupling: new insights into its pathogenesis and therapeutic possibilities Am. J. Physiol. Endocrinol. Metab. 302 2012 E481 495
213. M.J. Crabtree, and K.M. Channon Synthesis and recycling of tetrahydrobiopterin in endothelial function and vascular disease Nitric Oxide 25 2011 81 88
214. A. Sanchez, C. Contreras, M.P. Martinez, B. Climent, S. Benedito, A. Garcia-Sacristan, M. Hernandez, and D. Prieto Role of neural NO synthase (nNOS) uncoupling in the dysfunctional nitrergic vasorelaxation of penile arteries from insulin-resistant obese Zucker rats PLoS One 7 2012 e36027
215. J. Molnar, S. Yu, N. Mzhavia, C. Pau, I. Chereshnev, and H.M. Dansky Diabetes induces endothelial dysfunction but does not increase neointimal formation in high-fat diet fed C57BL/6J mice Circ. Res. 96 2005 1178 1184 (Pubitemid 40827693)
216. S.V. Brodsky, O. Gealekman, J. Chen, F. Zhang, N. Togashi, M. Crabtree, S.S. Gross, A. Nasjletti, and M.S. Goligorsky Prevention and reversal of premature endothelial cell senescence and vasculopathy in obesity-induced diabetes by ebselen Circ. Res. 94 2004 377 384 (Pubitemid 38240730)
217. J. Cassuto, H. Dou, I. Czikora, A. Szabo, V.S. Patel, and V. Kamath Belin de Chantemele, E.; Feher, A.; Romero, M. J.; Bagi, Z. Peroxynitrite disrupts endothelial caveolae leading to eNOS uncoupling and diminished flow-mediated dilation in coronary arterioles of diabetic patients Diabetes 63 2014 1381 1393
218. U. Landmesser, S. Dikalov, S.R. Price, L. McCann, T. Fukai, S.M. Holland, W.E. Mitch, and D.G. Harrison Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension J. Clin. Invest. 111 2003 1201 1209 (Pubitemid 36519937)
219. M. Satoh, S. Fujimoto, Y. Haruna, S. Arakawa, H. Horike, N. Komai, T. Sasaki, K. Tsujioka, H. Makino, and N. Kashihara NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy Am. J. Physiol. Renal Physiol 288 2005 F1144 1152
220. M.S. Bitar, S. Wahid, S. Mustafa, E. Al-Saleh, G.S. Dhaunsi, and F. Al-Mulla Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes Eur. J. Pharmacol. 511 2005 53 64 (Pubitemid 40380644)
221. J. Xu, Z. Xie, R. Reece, D. Pimental, and M.H. Zou Uncoupling of endothelial nitric oxidase synthase by hypochlorous acid: role of NAD(P)H oxidase-derived superoxide and peroxynitrite Arterioscler. Thromb. Vasc. Biol. 26 2006 2688 2695
222. A.E. Dikalova, M.C. Gongora, D.G. Harrison, J.D. Lambeth, S. Dikalov, and K.K. Griendling Upregulation of Nox1 in vascular smooth muscle leads to impaired endothelium-dependent relaxation via eNOS uncoupling Am. J. Physiol. Heart Circ. Physiol 299 2010 H673 679
223. Q. Zhang, P. Malik, D. Pandey, S. Gupta, D. Jagnandan, E. Belin de Chantemele, B. Banfi, M.B. Marrero, R.D. Rudic, D.W. Stepp, and D.J. Fulton Paradoxical activation of endothelial nitric oxide synthase by NADPH oxidase Arterioscler. Thromb. Vasc. Biol. 28 2008 1627 1633
224. W.H. Koppenol 100 years of peroxynitrite chemistry and 11 years of peroxynitrite biochemistry Redox Rep. 6 2001 339 341 (Pubitemid 34134324)
225. K. Toutouzas, M. Riga, E. Stefanadi, and C. Stefanadis Asymmetric dimethylarginine (ADMA) and other endogenous nitric oxide synthase (NOS) inhibitors as an important cause of vascular insulin resistance Horm. Metab. Res. 40 2008 655 659
226. M.G. Risbano, and M.T. Gladwin Therapeutics targeting of dysregulated redox equilibrium and endothelial dysfunction Handb. Exp. Pharmacol 218 2013 315 349
227. C.A. Chen, T.Y. Wang, S. Varadharaj, L.A. Reyes, C. Hemann, M.A. Talukder, Y.R. Chen, L.J. Druhan, and J.L. Zweier S-glutathionylation uncouples eNOS and regulates its cellular and vascular function Nature 468 2010 1115 1118
228. H. Lei, S. Luo, H. Qin, and Y. Xia Molecular mechanisms of endothelial NO synthase uncoupling Curr. Pharm. Des 20 2013 3548 3553
229. I.L. Williams, S.B. Wheatcroft, A.M. Shah, and M.T. Kearney Obesity, atherosclerosis and the vascular endothelium: mechanisms of reduced nitric oxide bioavailability in obese humans Int. J. Obes. Relat. Metab. Disord 26 2002 754 764 (Pubitemid 34620866)
230. H.O. Steinberg, H. Chaker, R. Leaming, A. Johnson, G. Brechtel, and A.D. Baron Obesity/insulin resistance is associated with endothelial dysfunction: implications for the syndrome of insulin resistance J. Clin. Invest. 97 1996 2601 2610
231. H. Laine, H. Yki-Jarvinen, O. Kirvela, T. Tolvanen, M. Raitakari, O. Solin, M. Haaparanta, J. Knuuti, and P. Nuutila Insulin resistance of glucose uptake in skeletal muscle cannot be ameliorated by enhancing endothelium-dependent blood flow in obesity J. Clin. Invest. 101 1998 1156 1162 (Pubitemid 28125295)
232. G.P. Van Guilder, B.L. Stauffer, J.J. Greiner, and C.A. Desouza Impaired endothelium-dependent vasodilation in overweight and obese adult humans is not limited to muscarinic receptor agonists Am. J. Physiol. Heart Circ. Physiol 294 2008 H1685 1692
233. G. Arcaro, M. Zamboni, L. Rossi, E. Turcato, G. Covi, F. Armellini, O. Bosello, and A. Lechi Body fat distribution predicts the degree of endothelial dysfunction in uncomplicated obesity Int. J. Obes. Relat. Disord 23 1999 936 942 (Pubitemid 29423936)
234. C.J. Tack, M.K. Ong, J.A. Lutterman, and P. Smits Insulin-induced vasodilatation and endothelial function in obesity/insulin resistance: effects of troglitazone Diabetologia 41 1998 569 576 (Pubitemid 28206828)
235. J. Westerbacka, S. Vehkavaara, R. Bergholm, I. Wilkinson, J. Cockcroft, and H. Yki-Jarvinen Marked resistance of the ability of insulin to decrease arterial stiffness characterizes human obesity Diabetes 48 1999 821 827 (Pubitemid 29153082)
236. W. Sturm, A. Sandhofer, J. Engl, M. Laimer, C. Molnar, S. Kaser, H. Weiss, H. Tilg, C.F. Ebenbichler, and J.R. Patsch Influence of visceral obesity and liver fat on vascular structure and function in obese subjects Obesity 17 2009 1783 1788
237. N.I. Parikh, M.J. Keyes, M.G. Larson, K.M. Pou, N.M. Hamburg, J.A. Vita, C.J. O'Donnell, R.S. Vasan, G.F. Mitchell, U. Hoffmann, C.S. Fox, and E.J. Benjamin Visceral and subcutaneous adiposity and brachial artery vasodilator function Obesity 17 2009 2054 2059
238. A.K. Gupta, G. Cornelissen, F.L. Greenway, V. Dhoopati, F. Halberg, and W.D. Johnson Abnormalities in circadian blood pressure variability and endothelial function: pragmatic markers for adverse cardiometabolic profiles in asymptomatic obese adults Cardiovasc. Diabetol. 9 2010 58
239. G. Grassi, G. Seravalle, F. Scopelliti, R. Dell'Oro, L. Fattori, F. Quarti-Trevano, G. Brambilla, E.L. Schiffrin, and G. Mancia Structural and functional alterations of subcutaneous small resistance arteries in severe human obesity Obesity 18 2010 92 98
240. B.R. Weil, C.M. Westby, G.P. Van Guilder, J.J. Greiner, B.L. Stauffer, and C.A. DeSouza Enhanced endothelin-1 system activity with overweight and obesity Am. J. Physiol. Heart Circ. Physiol 301 2011 H689 695
241. E. Lambert, C.I. Sari, T. Dawood, J. Nguyen, M. McGrane, N. Eikelis, R. Chopra, C. Wong, K. Chatzivlastou, G. Head, N. Straznicky, M. Esler, M. Schlaich, and G. Lambert Sympathetic nervous system activity is associated with obesity-induced subclinical organ damage in young adults Hypertension 56 2010 351 358
242. K.A. Han, Y. Patel, A.A. Lteif, R. Chisholm, and K.J. Mather Contributions of dysglycaemia, obesity, and insulin resistance to impaired endothelium-dependent vasodilation in humans Diabetes Metab. Res. Rev 27 2011 354 361
243. J. Andersson, L.G. Sjostrom, M. Karlsson, U. Wiklund, M. Hultin, F. Karpe, and T. Olsson Dysregulation of subcutaneous adipose tissue blood flow in overweight postmenopausal women Menopause 17 2010 365 371
244. H. Miadi-Messaoud, A. Chouchane, E. Abderrazek, H. Debbabi, M. Zaouali-Ajina, Z. Tabka, and A. Ben-Jebria Obesity-induced impairment of endothelium-dependent vasodilation in Tunisian women Int. J. Obes. 34 2010 273 279
245. F.H. Mahmud, D.J. Hill, M.S. Cuerden, and C.L. Clarson Impaired vascular function in obese adolescents with insulin resistance J. Pediatr. 155 2009 678 682
246. R. Bhattacharjee, W.H. Alotaibi, L. Kheirandish-Gozal, O.S. Capdevila, and D. Gozal Endothelial dysfunction in obese non-hypertensive children without evidence of sleep disordered breathing BMC Pediatr. 10 2010 8
247. R. Bhattacharjee, J. Kim, W.H. Alotaibi, L. Kheirandish-Gozal, O.S. Capdevila, and D. Gozal Endothelial dysfunction in children without hypertension: potential contributions of obesity and obstructive sleep apnea Chest 141 2012 682 691
248. M. El Assar, J.C. Ruiz de Adana, J. Angulo, M.L. Pindado Martinez, A. Hernandez Matias, and L. Rodriguez-Manas Preserved endothelial function in human obesity in the absence of insulin resistance J. Transl. Med. 11 2013 263
249. L.M. Biasucci, F. Graziani, V. Rizzello, G. Liuzzo, C. Guidone, A.R. De Caterina, S. Brugaletta, G. Mingrone, and F. Crea Paradoxical preservation of vascular function in severe obesity Am. J. Med. 123 2010 727 734
250. S. Czernichow, J.R. Greenfield, P. Galan, J.P. Bastard, N. Charnaux, K. Samaras, M.E. Safar, J. Blacher, S. Hercberg, and B.I. Levy Microvascular dysfunction in healthy insulin-sensitive overweight individuals J. Hypertens. 28 2010 325 332
251. J.E. Morley, and J.F. Flood Evidence that nitric oxide modulates food intake in mice Life Sci. 49 1991 707 711
252. J.E. Morley, and J.F. Flood Competitive antagonism of nitric oxide synthetase causes weight loss in mice Life Sci. 51 1992 1285 1289
253. J.E. Morley, and J.F. Flood Effect of competitive antagonism of NO synthetase on weight and food intake in obese and diabetic mice Am. J. Physiol. 266 1994 R164 168
254. F. Squadrito, G. Calapai, D. Cucinotta, D. Altavilla, B. Zingarelli, M. Ioculano, G. Urna, A. Sardella, G.M. Campo, and A.P. Caputi Anorectic activity of NG-nitro-L-arginine, an inhibitor of brain nitric oxide synthase, in obese Zucker rats Eur. J. Pharmacol. 230 1993 125 128 (Pubitemid 23024993)
255. G. Calapai, F. Corica, A. Allegra, A. Corsonello, L. Sautebin, T. De Gregorio, M. Di Rosa, G. Costantino, M. Buemi, and A.P. Caputi Effects of intracerebroventricular leptin administration on food intake, body weight gain and diencephalic nitric oxide synthase activity in the mouse Br. J. Pharmacol. 125 1998 798 802 (Pubitemid 28482622)
256. A. Iuras, M.M. Telles, C.R. Bertoncini, G.M. Ko, I.S. de Andrade, V.L. Silveira, and E.B. Ribeiro Central administration of a nitric oxide precursor abolishes both the hypothalamic serotonin release and the hypophagia induced by interleukin-1beta in obese Zucker rats Regul. Pept. 124 2005 145 150 (Pubitemid 39488352)
257. F. Squadrito, G. Calapai, D. Altavilla, D. Cucinotta, B. Zingarelli, V. Arcoraci, G.M. Campo, and A.P. Caputi Central serotoninergic system involvement in the anorexia induced by NG-nitro-L-arginine, an inhibitor of nitric oxide synthase Eur. J. Pharmacol. 255 1994 51 55 (Pubitemid 24105743)
258. A. Stricker-Krongrad, B. Beck, and C. Burlet Nitric oxide mediates hyperphagia of obese Zucker rats: relation to specific changes in the microstructure of feeding behavior Life Sci. 58 1996 (PL9-15)
259. K. Tsuchiya, H. Sakai, N. Suzuki, F. Iwashima, T. Yoshimoto, M. Shichiri, and Y. Hirata Chronic blockade of nitric oxide synthesis reduces adiposity and improves insulin resistance in high fat-induced obese mice Endocrinology 148 2007 4548 4556 (Pubitemid 47481508)
260. R. Shankar, J.S. Zhu, B. Ladd, D. Henry, H.Q. Shen, and A.D. Baron Central nervous system nitric oxide synthase activity regulates insulin secretion and insulin action J. Clin. Invest. 102 1998 1403 1412 (Pubitemid 28467569)
261. J. Rodin Insulin levels, hunger, and food intake: an example of feedback loops in body weight regulation Health Psychol. 4 1985 1 24
262. J. Rodin, J. Wack, E. Ferrannini, and R.A. DeFronzo Effect of insulin and glucose on feeding behavior Metabolism 34 1985 826 831 (Pubitemid 15239313)
263. J. Louis-Sylvestre Meal size: role of reflexly induced insulin release J. Auton. Nerv. Syst. 10 1984 317 324 (Pubitemid 14092091)
264. S.C. Woods, and J. Gibbs The regulation of food intake by peptides Ann. N. Y. Acad. Sci. 575 1989 236 243 (Pubitemid 20119009)
265. R.U. Pliquett, D. Fuhrer, S. Falk, S. Zysset, D.Y. von Cramon, and M. Stumvoll The effects of insulin on the central nervous system - focus on appetite regulation Horm. Metab. Res. 38 2006 442 446 (Pubitemid 44298771)
266. J. Yamada, Y. Sugimoto, T. Yoshikawa, and K. Horisaka Effects of a nitric oxide synthase inhibitor on 5-HT1A receptor agonist 8-OH-DPAT-induced hyperphagia in rats Eur. J. Pharmacol. 316 1996 23 26 (Pubitemid 26426924)
267. Y. Sugimoto, J. Yamada, and T. Yoshikawa A neuronal nitric oxide synthase inhibitor 7-nitroindazole reduces the 5-HT1A receptor against 8-OH-DPAT-elicited hyperphagia in rats Eur. J. Pharmacol. 376 1999 1 5 (Pubitemid 29320163)
268. Y. Sugimoto, T. Yoshikawa, and J. Yamada Involvement of nitric oxide in the 5-HT1A autoreceptor-mediated hyperphagia in rats Adv. Exp. Med. Biol. 467 1999 109 111
269. D.A. Czech, M.R. Kazel, and J. Harris A nitric oxide synthase inhibitor, N(G)-nitro-L-arginine methyl ester, attenuates lipoprivic feeding in mice Physiol. Behav. 80 2003 75 79 (Pubitemid 37249375)
270. M. Li, M.A. Vizzard, D.M. Jaworski, and R.A. Galbraith The weight loss elicited by cobalt protoporphyrin is related to decreased activity of nitric oxide synthase in the hypothalamus J. Appl. Physiol. (1985) 100 2006 1983 1991 (Pubitemid 43845874)
271. T.C. Wascher, W.F. Graier, P. Dittrich, M.A. Hussain, B. Bahadori, S. Wallner, and H. Toplak Effects of low-dose L-arginine on insulin-mediated vasodilatation and insulin sensitivity Eur. J. Clin. Invest. 27 1997 690 695 (Pubitemid 27368301)
272. P. Lucotti, E. Setola, L.D. Monti, E. Galluccio, S. Costa, E.P. Sandoli, I. Fermo, G. Rabaiotti, R. Gatti, and P. Piatti Beneficial effects of a long-term oral L-arginine treatment added to a hypocaloric diet and exercise training program in obese, insulin-resistant type 2 diabetic patients Am. J. Physiol. Endocrinol. Metab. 291 2006 E906 912
273. M. Alizadeh, A. Safaeiyan, A. Ostadrahimi, R. Estakhri, S. Daneghian, A. Ghaffari, and B.P. Gargari Effect of L-arginine and selenium added to a hypocaloric diet enriched with legumes on cardiovascular disease risk factors in women with central obesity: a randomized, double-blind, placebo-controlled trial Ann. Nutr. Metab. 60 2012 157 168
274. P. Bogdanski, J. Suliburska, K. Grabanska, K. Musialik, A. Cieslewicz, A. Skoluda, and A. Jablecka Effect of 3-month L-arginine supplementation on insulin resistance and tumor necrosis factor activity in patients with visceral obesity Eur. Rev. Med. Sci 16 2012 816 823
275. P. Bogdanski, M. Szulinska, J. Suliburska, D. Pupek-Musialik, A. Jablecka, and H. Witmanowski Supplementation with L-arginine favorably influences plasminogen activator inhibitor type 1 concentration in obese patients: a randomized, double blind trial J. Endocrinol. Invest. 36 2013 221 226
276. J. Suliburska, P. Bogdanski, M. Szulinska, D. Pupek-Musialik, and A. Jablecka Changes in mineral status are associated with improvements in insulin sensitivity in obese patients following L-arginine supplementation Eur. J. Nutr. 53 2014 387 393
277. L.D. Monti, M.C. Casiraghi, E. Setola, E. Galluccio, M.A. Pagani, L. Quaglia, E. Bosi, and P. Piatti L-Arginine enriched biscuits improve endothelial function and glucose metabolism: a pilot study in healthy subjects and a cross-over study in subjects with impaired glucose tolerance and metabolic syndrome Metabolism 62 2013 255 264
278. C. Clemmensen, A.N. Madsen, S. Smajilovic, B. Holst, and H. Brauner-Osborne L-Arginine improves multiple physiological parameters in mice exposed to diet-induced metabolic disturbances Amino Acids 43 2012 1265 1275
279. W.J. Fu, T.E. Haynes, R. Kohli, J. Hu, W. Shi, T.E. Spencer, R.J. Carroll, C.J. Meininger, and G. Wu Dietary L-arginine supplementation reduces fat mass in Zucker diabetic fatty rats J. Nutr. 135 2005 714 721 (Pubitemid 40464093)
280. W. Jobgen, C.J. Meininger, S.C. Jobgen, P. Li, M.J. Lee, S.B. Smith, T.E. Spencer, S.K. Fried, and G. Wu Dietary L-arginine supplementation reduces white fat gain and enhances skeletal muscle and brown fat masses in diet-induced obese rats J. Nutr. 139 2009 230 237
281. B. Tan, Y. Yin, Z. Liu, X. Li, H. Xu, X. Kong, R. Huang, W. Tang, I. Shinzato, S.B. Smith, and G. Wu Dietary L-arginine supplementation increases muscle gain and reduces body fat mass in growing-finishing pigs Amino Acids 37 2009 169 175
282. J.R. McKnight, M.C. Satterfield, W.S. Jobgen, S.B. Smith, T.E. Spencer, C.J. Meininger, C.J. McNeal, and G. Wu Beneficial effects of L-arginine on reducing obesity: potential mechanisms and important implications for human health Amino Acids 39 2010 349 357
283. J.E. Ayala, D.P. Bracy, B.M. Julien, J.N. Rottman, P.T. Fueger, and D.H. Wasserman Chronic treatment with sildenafil improves energy balance and insulin action in high fat-fed conscious mice Diabetes 56 2007 1025 1033 (Pubitemid 46525081)
284. M.M. Mitschke, L.S. Hoffmann, T. Gnad, D. Scholz, K. Kruithoff, P. Mayer,
285. L. De Toni, G. Strapazzon, L. Gianesello, N. Caretta, C. Pilon, A. Bruttocao, and C. Foresta Effects of type 5-phosphodiesterase inhibition on energy metabolism and mitochondrial biogenesis in human adipose tissue ex vivo J. Endocrinol. Invest. 34 2011 738 741
286. H. Wang, A.X. Wang, K. Aylor, and E.J. Barrett Nitric oxide directly promotes vascular endothelial insulin transport Diabetes 62 2013 4030 4042
287. A.D. Baron, J.S. Zhu, S. Marshall, O. Irsula, G. Brechtel, and C. Keech Insulin resistance after hypertension induced by the nitric oxide synthesis inhibitor L-NMMA in rats Am. J. Physiol. 269 1995 E709 715
288. R. Meshkani, and K. Adeli Hepatic insulin resistance, metabolic syndrome and cardiovascular disease Clin. Biochem. 42 2009 1331 1346
289. C.J. Meininger, R.S. Marinos, K. Hatakeyama, R. Martinez-Zaguilan, J.D. Rojas, K.A. Kelly, and G. Wu Impaired nitric oxide production in coronary endothelial cells of the spontaneously diabetic BB rat is due to tetrahydrobiopterin deficiency Biochem. J. 349 2000 353 356 (Pubitemid 30440201)
290. J. Xu, Y. Wu, P. Song, M. Zhang, S. Wang, and M.H. Zou Proteasome-dependent degradation of guanosine 5′-triphosphate cyclohydrolase I causes tetrahydrobiopterin deficiency in diabetes mellitus Circulation 116 2007 944 953 (Pubitemid 47300919)
291. C.J. Meininger, S. Cai, J.L. Parker, K.M. Channon, K.A. Kelly, E.J. Becker, M.K. Wood, L.A. Wade, and G. Wu GTP cyclohydrolase I gene transfer reverses tetrahydrobiopterin deficiency and increases nitric oxide synthesis in endothelial cells and isolated vessels from diabetic rats FASEB J 18 2004 1900 1902 (Pubitemid 39602277)
292. A. Abudukadier, Y. Fujita, A. Obara, A. Ohashi, T. Fukushima, Y. Sato, M. Ogura, Y. Nakamura, S. Fujimoto, M. Hosokawa, H. Hasegawa, and N. Inagaki Tetrahydrobiopterin has a glucose-lowering effect by suppressing hepatic gluconeogenesis in an endothelial nitric oxide synthase-dependent manner in diabetic mice Diabetes 62 2013 3033 3043
293. P. Sadri, and W.W. Lautt Blockade of hepatic nitric oxide synthase causes insulin resistance Am. J. Physiol. 277 1999 G101 108
294. M.P. Guarino, R.A. Afonso, N. Raimundo, J.F. Raposo, and M.P. Macedo Hepatic glutathione and nitric oxide are critical for hepatic insulin-sensitizing substance action Am. J. Physiol. Gastrointest. Liver Physiol. 284 2003 G588 594
295. M.P. Guarino, and M.P. Macedo Co-administration of glutathione and nitric oxide enhances insulin sensitivity in Wistar rats Br. J. Pharmacol. 147 2006 959 965
296. I. Sosa, O. Cvijanovic, T. Celic, D. Cuculic, Z. Crncevic-Orlic, L. Vukelic, S. Zoricic Cvek, L. Dudaric, A. Bosnar, and D. Bobinac Hepatoregenerative role of bone morphogenetic protein-9 Med. Sci. Monit. 17 2011 HY33 35
297. W.W. Lautt A new paradigm for diabetes and obesity: the hepatic insulin sensitizing substance (HISS) hypothesis J. Pharmacol. Sci. 95 2004 9 17 (Pubitemid 38856040)
298. W.W. Lautt Insulin sensitivity in skeletal muscle regulated by a hepatic hormone, HISS Can. J. Appl. Physiol. 30 2005 304 312 (Pubitemid 40880710)
299. Z. Ming, and W.W. Lautt HISS, not insulin, causes vasodilation in response to administered insulin J. Appl. Physiol. (1985) 110 2011 60 68
300. H.O. Steinberg, G. Brechtel, A. Johnson, N. Fineberg, and A.D. Baron Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent: a novel action of insulin to increase nitric oxide release J. Clin. Invest. 94 1994 1172 1179
301. U. Scherrer, D. Randin, P. Vollenweider, L. Vollenweider, and P. Nicod Nitric oxide release accounts for insulin's vascular effects in humans J. Clin. Invest. 94 1994 2511 2515 (Pubitemid 24379629)
302. A.D. Baron Hemodynamic actions of insulin Am. J. Physiol. 267 1994 E187 202
303. M.P. Guarino, N.C. Correia, W.W. Lautt, and M.P. Macedo Insulin sensitivity is mediated by the activation of the ACh/NO/cGMP pathway in rat liver Am. J. Physiol. Gastrointest. Liver Physiol. 287 2004 G527 532
304. M.P. Guarino, N.C. Correia, J. Raposo, and M.P. Macedo Nitric oxide synthase inhibition decreases output of hepatic insulin sensitizing substance (HISS), which is reversed by SIN-1 but not by nitroprusside Proc. West. Pharmacol. Soc. 44 2001 25 26 (Pubitemid 34087701)
305. W.W. Lautt, M.P. Macedo, P. Sadri, S. Takayama, F. Duarte Ramos, and D.J. Legare Hepatic parasympathetic (HISS) control of insulin sensitivity determined by feeding and fasting Am. J. Physiol. Gastrointest. Liver Physiol. 281 2001 G29 36
306. S.G. Barreto, C.J. Carati, J. Toouli, and G.T. Saccone The islet-acinar axis of the pancreas: more than just insulin Am. J. Physiol. Gastrointest. Liver Physiol. 299 2010 G10 22
307. W.Y. Chey, and T. Chang Neural hormonal regulation of exocrine pancreatic secretion Pancreatology 1 2001 320 335 (Pubitemid 33758409)
308. S.R. Vincent Nitric oxide and arginine-evoked insulin secretion Science 258 1992 1376 1378 (Pubitemid 23007793)
309. K.A. Broniowska, B.J. Oleson, and J. Corbett A. beta-Cell responses to nitric oxide Vitam. Horm. 95 2014 299 322
310. T. Takamura, I. Kato, N. Kimura, T. Nakazawa, H. Yonekura, S. Takasawa, and H. Okamoto Transgenic mice overexpressing type 2 nitric-oxide synthase in pancreatic beta cells develop insulin-dependent diabetes without insulitis J. Biol. Chem. 273 1998 2493 2496 (Pubitemid 28133886)
311. S.G. Laychock, M.E. Modica, and C.T. Cavanaugh L-Arginine stimulates cyclic guanosine 3′,5′-monophosphate formation in rat islets of Langerhans and RINm5F insulinoma cells: evidence for L-arginine:nitric oxide synthase Endocrinology 129 1991 3043 3052
312. H.H. Schmidt, T.D. Warner, K. Ishii, H. Sheng, and F. Murad Insulin secretion from pancreatic B cells caused by L-arginine-derived nitrogen oxides Science 255 1992 721 723
313. G.A. Spinas, R. Laffranchi, I. Francoys, I. David, C. Richter, and M. Reinecke The early phase of glucose-stimulated insulin secretion requires nitric oxide Diabetologia 41 1998 292 299 (Pubitemid 28254823)
314. G.A. Spinas The dual role of nitric oxide in islet beta-cells News Physiol. Sci. 14 1999 49 54
315. R. Laffranchi, V. Gogvadze, C. Richter, and G.A. Spinas Nitric oxide (nitrogen monoxide, NO) stimulates insulin secretion by inducing calcium release from mitochondria Biochem. Biophys. Res. Commun. 217 1995 584 591 (Pubitemid 26011751)
316. P.M. Jones, S.J. Persaud, T. Bjaaland, J.D. Pearson, and S.L. Howell Nitric oxide is not involved in the initiation of insulin secretion from rat islets of Langerhans Diabetologia 35 1992 1020 1027
317. N. Weigert, M. Dollinger, R. Schmid, and V. Schusdziarra Contribution of neural intrapancreatic non-cholinergic non-adrenergic mechanisms to glucose-induced insulin release in the isolated rat pancreas Diabetologia 35 1992 1133 1139
318. K. Ohtoshi, Y. Yamasaki, S. Gorogawa, R. Hayaishi-Okano, K. Node, M. Matsuhisa, Y. Kajimoto, and M. Hori Association of (-)786T-C mutation of endothelial nitric oxide synthase gene with insulin resistance Diabetologia 45 2002 1594 1601 (Pubitemid 35352054)
319. T. Yoshimura, A. Hisatomi, S. Kajihara, T. Yasutake, Y. Ogawa, T. Mizuta, I. Ozaki, T. Utsunomiyai, and K. Yamamoto The relationship between insulin resistance and polymorphisms of the endothelial nitric oxide synthase gene in patients with coronary artery disease J. Atheroscler. Thromb. 10 2003 43 47
320. C. Vecoli, M.G. Andreassi, R. Liga, M.G. Colombo, M. Coceani, C. Carpeggiani, A. L'Abbate, and D. Neglia T(-786)→C polymorphism of the endothelial nitric oxide synthase gene is associated with insulin resistance in patients with ischemic or non ischemic cardiomyopathy BMC Med. Genet. 13 2012 92
321. L.D. Monti, C. Barlassina, L. Citterio, E. Galluccio, C. Berzuini, E. Setola, G. Valsecchi, P. Lucotti, G. Pozza, L. Bernardinelli, G. Casari, and P. Piatti Endothelial nitric oxide synthase polymorphisms are associated with type 2 diabetes and the insulin resistance syndrome Diabetes 52 2003 1270 1275 (Pubitemid 36523367)
322. J.L. Gonzalez-Sanchez, M.T. Martinez-Larrad, M.E. Saez, C. Zabena, M.J. Martinez-Calatrava, and M. Serrano-Rios Endothelial nitric oxide synthase haplotypes are associated with features of metabolic syndrome Clin. Chem. 53 2007 91 97 (Pubitemid 46047767)
323. K. Rittig, K. Holder, J. Stock, O. Tschritter, A. Peter, N. Stefan, A. Fritsche, F. Machicao, H.U. Haring, and B. Balletshofer Endothelial NO-synthase intron 4 polymorphism is associated with disturbed in vivo nitric oxide production in individuals prone to type 2 diabetes Horm. Metab. Res. 40 2008 13 17 (Pubitemid 351204819)
324. B.J. Morris, C.L. Glenn, D.E. Wilcken, and X.L. Wang Influence of an inducible nitric oxide synthase promoter variant on clinical variables in patients with coronary artery disease Clin. Sci. 100 2001 551 556 (Pubitemid 32434121)
325. R.A. Bagarolli, M.J. Saad, and S.T. Saad Toll-like receptor 4 and inducible nitric oxide synthase gene polymorphisms are associated with type 2 diabetes J. Diabetes Complications 24 2010 192 198
326. H. Duplain, R. Burcelin, C. Sartori, S. Cook, M. Egli, M. Lepori, P. Vollenweider, T. Pedrazzini, P. Nicod, B. Thorens, and U. Scherrer Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase Circulation 104 2001 342 345 (Pubitemid 32666958)
327. S. Cook, O. Hugli, M. Egli, B. Menard, S. Thalmann, C. Sartori, C. Perrin, P. Nicod, B. Thorens, P. Vollenweider, U. Scherrer, and R. Burcelin Partial gene deletion of endothelial nitric oxide synthase predisposes to exaggerated high-fat diet-induced insulin resistance and arterial hypertension Diabetes 53 2004 2067 2072 (Pubitemid 38970756)
328. S. Cook, O. Hugli, M. Egli, P. Vollenweider, R. Burcelin, P. Nicod, B. Thorens, and U. Scherrer Clustering of cardiovascular risk factors mimicking the human metabolic syndrome X in eNOS null mice Swiss Med. Wkly. 133 2003 360 363 (Pubitemid 37064561)
329. R.R. Shankar, Y. Wu, H.Q. Shen, J.S. Zhu, and A.D. Baron Mice with gene disruption of both endothelial and neuronal nitric oxide synthase exhibit insulin resistance Diabetes 49 2000 684 687 (Pubitemid 30339980)
330. S. Nakata, M. Tsutsui, H. Shimokawa, O. Suda, T. Morishita, K. Shibata, Y. Yatera, K. Sabanai, A. Tanimoto, M. Nagasaki, H. Tasaki, Y. Sasaguri, Y. Nakashima, Y. Otsuji, and N. Yanagihara Spontaneous myocardial infarction in mice lacking all nitric oxide synthase isoforms Circulation 117 2008 2211 2223
331. K. Sydow, C.E. Mondon, J. Schrader, H. Konishi, and J.P. Cooke Dimethylarginine dimethylaminohydrolase overexpression enhances insulin sensitivity Arterioscler. Thromb. Vasc. Biol. 28 2008 692 697 (Pubitemid 351651348)
332. E. Le Gouill, M. Jimenez, C. Binnert, P.Y. Jayet, S. Thalmann, P. Nicod, U. Scherrer, and P. Vollenweider Endothelial nitric oxide synthase (eNOS) knockout mice have defective mitochondrial beta-oxidation Diabetes 56 2007 2690 2696 (Pubitemid 350044910)
333. R.S. Lee-Young, J.E. Ayala, C.F. Hunley, F.D. James, D.P. Bracy, L. Kang, and D.H. Wasserman Endothelial nitric oxide synthase is central to skeletal muscle metabolic regulation and enzymatic signaling during exercise in vivo Am. J. Physiol. Regul. Integr. Comp. Physiol 298 2010 R1399 1408
334. M. Carlstrom, F.J. Larsen, T. Nystrom, M. Hezel, S. Borniquel, E. Weitzberg, and J.O. Lundberg Dietary inorganic nitrate reverses features of metabolic syndrome in endothelial nitric oxide synthase-deficient mice Proc. Natl. Acad. Sci. USA 107 2010 17716 17720
335. D.N. Atochin, and P.L. Huang Endothelial nitric oxide synthase transgenic models of endothelial dysfunction Pflugers Arch. 460 2010 965 974
336. S. Kashiwagi, D.N. Atochin, Q. Li, M. Schleicher, T. Pong, W.C. Sessa, and P.L. Huang eNOS phosphorylation on serine 1176 affects insulin sensitivity and adiposity Biochem. Biophys. Res. Commun. 431 2013 284 290
337. A. Khedara, Y. Kawai, J. Kayashita, and N. Kato Feeding rats the nitric oxide synthase inhibitor, L-N(omega)nitroarginine, elevates serum triglyceride and cholesterol and lowers hepatic fatty acid oxidation J. Nutr. 126 1996 2563 2567 (Pubitemid 26339671)
338. A. Khedara, T. Goto, M. Morishima, J. Kayashita, and N. Kato Elevated body fat in rats by the dietary nitric oxide synthase inhibitor, L-N omega nitroarginine Biosci. Biotechnol. Biochem. 63 1999 698 702 (Pubitemid 129549260)
339. F.A. Recchia, J.C. Osorio, M.P. Chandler, X. Xu, A.R. Panchal, G.D. Lopaschuk, T.H. Hintze, and W.C. Stanley Reduced synthesis of NO causes marked alterations in myocardial substrate metabolism in conscious dogs Am. J. Physiol. Endocrinol. Metab. 282 2002 E197 206
340. J. Garcia-Villafranca, A. Guillen, and J. Castro Involvement of nitric oxide/cyclic GMP signaling pathway in the regulation of fatty acid metabolism in rat hepatocytes Biochem. Pharmacol. 65 2003 807 812 (Pubitemid 36293697)
341. T. Goto, S. Ohnomi, A. Khedara, N. Kato, H. Ogawa, and T. Yanagita Feeding the nitric oxide synthase inhibitor L-N(omega)nitroarginine elevates serum very low density lipoprotein and hepatic triglyceride synthesis in rats J. Nutr. Biochem. 10 1999 274 278 (Pubitemid 29219495)
342. L. Schild, F. Dombrowski, U. Lendeckel, C. Schulz, A. Gardemann, and G. Keilhoff Impairment of endothelial nitric oxide synthase causes abnormal fat and glycogen deposition in liver Biochim. Biophys. Acta 1782 2008 180 187
343. P. Lefebvre, G. Chinetti, J.C. Fruchart, and B. Staels Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis J. Clin. Invest. 116 2006 571 580 (Pubitemid 43326861)
344. P.T. Doulias, M. Tenopoulou, J.L. Greene, K. Raju, and H. Ischiropoulos Nitric oxide regulates mitochondrial fatty acid metabolism through reversible protein S-nitrosylation Sci. Signaling 6 2013 rs1
345. M. Perreault, and A. Marette Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle Nat. Med 7 2001 1138 1143 (Pubitemid 33010023)
346. M.A. Carvalho-Filho, M. Ueno, S.M. Hirabara, A.B. Seabra, J.B. Carvalheira, M.G. de Oliveira, L.A. Velloso, R. Curi, and M.J. Saad S-nitrosation of the insulin receptor, insulin receptor substrate 1, and protein kinase B/Akt: a novel mechanism of insulin resistance Diabetes 54 2005 959 967 (Pubitemid 40446309)
347. M.A. Carvalho-Filho, M. Ueno, J.B. Carvalheira, L.A. Velloso, and M.J. Saad Targeted disruption of iNOS prevents LPS-induced S-nitrosation of IRbeta/IRS-1 and Akt and insulin resistance in muscle of mice Am. J. Physiol. Endocrinol. Metab. 291 2006 E476 482
348. J.R. Pauli, E.R. Ropelle, D.E. Cintra, M.A. Carvalho-Filho, J.C. Moraes, C.T. De Souza, L.A. Velloso, J.B. Carvalheira, and M.J. Saad Acute physical exercise reverses S-nitrosation of the insulin receptor, insulin receptor substrate 1 and protein kinase B/Akt in diet-induced obese Wistar rats J. Physiol. 586 2008 659 671
349. R.T. Williamson On the treatment of glycosuria and diabetes mellitus with sodium salicylate Br. Med. J 1 1901 760 762
350. M.J. Smith, and B.W. Meade The effect of salicylate on glycosuria, blood glucose and liver glycogen of the alloxan-diabetic rat Biochem. J. 51 1952 18 20
351. R.S. Hundal, K.F. Petersen, A.B. Mayerson, P.S. Randhawa, S. Inzucchi, S.E. Shoelson, and G.I. Shulman Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes J. Clin. Invest. 109 2002 1321 1326 (Pubitemid 34546896)
352. J.K. Kim, Y.J. Kim, J.J. Fillmore, Y. Chen, I. Moore, J. Lee, M. Yuan, Z.W. Li, M. Karin, P. Perret, S.E. Shoelson, and G.I. Shulman Prevention of fat-induced insulin resistance by salicylate J. Clin. Invest. 108 2001 437 446 (Pubitemid 32730790)
353. M.A. Carvalho-Filho, E.R. Ropelle, R.J. Pauli, D.E. Cintra, D.M. Tsukumo, L.R. Silveira, R. Curi, J.B. Carvalheira, L.A. Velloso, and M.J. Saad Aspirin attenuates insulin resistance in muscle of diet-induced obese rats by inhibiting inducible nitric oxide synthase production and S-nitrosylation of IRbeta/IRS-1 and Akt Diabetologia 52 2009 2425 2434
354. S. Shinozaki, C.S. Choi, N. Shimizu, M. Yamada, M. Kim, T. Zhang, G. Shiota, H.H. Dong, Y.B. Kim, and M. Kaneki Liver-specific inducible nitric-oxide synthase expression is sufficient to cause hepatic insulin resistance and mild hyperglycemia in mice J. Biol. Chem. 286 2011 34959 34975
355. P. Handa, S. Tateya, N.O. Rizzo, A.M. Cheng, V. Morgan-Stevenson, C.Y. Han, A.W. Clowes, G. Daum, K.D. O'Brien, M.W. Schwartz, A. Chait, and F. Kim Reduced vascular nitric oxide-cGMP signaling contributes to adipose tissue inflammation during high-fat feeding Arterioscler. Thromb. Vasc. Biol. 31 2011 2827 2835
356. H.N. Cha, Y.W. Kim, J.Y. Kim, Y.D. Kim, I.H. Song, K.N. Min, and S.Y. Park Lack of inducible nitric oxide synthase does not prevent aging-associated insulin resistance Exp. Gerontol. 45 2010 711 718
357. C.M. Taniguchi, B. Emanuelli, and C.R. Kahn Critical nodes in signalling pathways: insights into insulin action Nat. Rev. Mol. Cell Biol. 7 2006 85 96 (Pubitemid 43278292)
358. P. Turini, S. Thalmann, P.Y. Jayet, S. Cook, C. Mathieu, R. Burcelin, P. Nicod, P. Vollenweider, C. Sartori, and U. Scherrer Insulin resistance in mice lacking neuronal nitric oxide synthase is related to an alpha-adrenergic mechanism Swiss Med. Wkly. 137 2007 700 704